BURZYKOWSKI, Tomasz

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Internal UHasselt:  BUYSE, Marc
Type:  Journal Contribution

Results 41-60 of 67 (Search time: 0.012 seconds).

Issue DateTitleContributor(s)TypeCat.
412008Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancerBURZYKOWSKI, Tomasz; BUYSE, Marc; Piccart-Gebhart, Martine J.; Sledge, George; Carmichael, James; Lueck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
422008The meta-analytic framework for the evaluation of surrogate endpoints in clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; BUYSE, MarcJournal ContributionA1
432008Exploring and validating surrogate endpoints in colorectal cancerBURZYKOWSKI, Tomasz; BUYSE, Marc; Yothers, Greg; Sakamoto, Junichi; Sargent, DanJournal ContributionA1
442008Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerPiccart-Gebhart, Martine J.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sledge, George; Carmichael, James; Luck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
452008Individual- and trial-level surrogacy in colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Michiels, Stefan; Carroll, KevinJournal ContributionA1
462007Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!Collette, Laurence; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
472007Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerde Gramont, Aimery; BUYSE, Marc; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Cervantes, Andres; Figer, Arie; Lledo, Gerard; Flesch, Michel; Mineur, Laurent; Carola, Elisabeth; Etienne, Pierre-Luc; Rivera, Fernando; Chirivella, Isabel; Perez-Staub, Nathalie; Louvet, Christophe; AndrĂ©, Thierry; Tabah-Fisch, Isabelle; Tournigand, ChristopheJournal ContributionA1
482007Progression-free survival is a surrogate for survival in advanced colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, Kevin; Michiels, Stefan; Sargent, Daniel J.; Miller, Langdon L.; Elfring, Gary L.; Pignon, Jean-Pierre; Piedbois, PascalJournal ContributionA1
492006Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validationBURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
502005A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancerBURZYKOWSKI, Tomasz; Piccart, MJ; Sledge, G; Carmichael, J; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Therasse, P; BUYSE, MarcJournal ContributionM
512005Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trialsPiccart, MJ; BURZYKOWSKI, Tomasz; Sledge, G; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Carmichael, J; BUYSE, Marc; Therasse, PJournal ContributionM
522005Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials.BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, K; Michiels, Stefan; Pignon, JP; Piedbois, PJournal ContributionM
532004Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpointsALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, MarcJournal ContributionA1
542004A perspective on surrogate endpoints in controlled clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, MarcJournal ContributionA1
552004Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trialsSakamoto, J.; Ohashi, Y.; Hamada, C.; BUYSE, Marc; BURZYKOWSKI, Tomasz; Piedbois, P.Journal ContributionA1
562004The validation of surrogate endpoints by using data from randomized clinical trials: a case-study in advanced colorectal cancerBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, MarcJournal ContributionA1
172003Simplified hierarchical linear models for the evaluation of surrogate endpointsTIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, RussJournal ContributionA1
182003Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, JanJournal ContributionA1
192003Validation of a longitudinally measured surrogate for a time-to-event endpointRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, LucJournal ContributionA1
202002Statistical challenges in the evaluation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, ArielJournal ContributionA1